NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Update

Posted by on Aug 26th, 2026

NewGenIvf Group Limited (NASDAQ:NIVF – Get Free Report) was the target of a large increase in short interest in the month of August. As of August 14th, there was short interest totaling 171,641 shares, an increase of 1,821.6% from the July 30th total of 8,932 shares. Based on an average daily trading volume, of 608,157 shares, the days-to-cover ratio is currently 0.3 days. Currently, 4.3% of the company’s shares are short sold.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on NIVF. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a report on Friday, July 24th. Wall Street Zen raised shares of NewGenIvf Group to a “hold” rating in a research report on Saturday, July 4th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

Get Our Latest Analysis on NewGenIvf Group

NewGenIvf Group Stock Performance

Shares of NASDAQ:NIVF opened at $0.55 on Wednesday. The stock has a fifty day simple moving average of $1.16 and a two-hundred day simple moving average of $4.16. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. NewGenIvf Group has a 12-month low of $0.45 and a 12-month high of $513.00.

NewGenIvf Group shares are going to reverse split on Tuesday, September 1st. The 1-3 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Monday, August 31st.

NewGenIvf Group Company Profile

(Get Free Report)

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.

Featured Stories

Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.